BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Revel-Mouroz P, Otal P, Jaffro M, Petermann A, Meyrignac O, Rabinel P, Mokrane FZ. Other non-surgical treatments for liver cancer. Rep Pract Oncol Radiother 2017;22:181-92. [PMID: 28490991 DOI: 10.1016/j.rpor.2017.02.007] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
Number Citing Articles
1 Granata V, Fusco R, Salati S, Petrillo A, Di Bernardo E, Grassi R, Palaia R, Danti G, La Porta M, Cadossi M, Gašljević G, Sersa G, Izzo F. A Systematic Review about Imaging and Histopathological Findings for Detecting and Evaluating Electroporation Based Treatments Response. Int J Environ Res Public Health 2021;18:5592. [PMID: 34073865 DOI: 10.3390/ijerph18115592] [Reference Citation Analysis]
2 Imajo K, Ogawa Y, Yoneda M, Saito S, Nakajima A. A review of conventional and newer generation microwave ablation systems for hepatocellular carcinoma.J Med Ultrason (2001). 2020;47:265-277. [PMID: 31960190 DOI: 10.1007/s10396-019-00997-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
3 Acciuffi S, Meyer F, Bauschke A, Croner R, Settmacher U, Altendorf-Hofmann A. Solitary colorectal liver metastasis: overview of treatment strategies and role of prognostic factors. J Cancer Res Clin Oncol 2021. [PMID: 34914005 DOI: 10.1007/s00432-021-03880-4] [Reference Citation Analysis]
4 Pérez-López A, Martín-Sabroso C, Torres-Suárez AI, Aparicio-Blanco J. Timeline of Translational Formulation Technologies for Cancer Therapy: Successes, Failures, and Lessons Learned Therefrom. Pharmaceutics 2020;12:E1028. [PMID: 33126622 DOI: 10.3390/pharmaceutics12111028] [Reference Citation Analysis]
5 Granata V, Grassi R, Fusco R, Belli A, Cutolo C, Pradella S, Grazzini G, La Porta M, Brunese MC, De Muzio F, Ottaiano A, Avallone A, Izzo F, Petrillo A. Diagnostic evaluation and ablation treatments assessment in hepatocellular carcinoma. Infect Agent Cancer 2021;16:53. [PMID: 34281580 DOI: 10.1186/s13027-021-00393-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Izzo F, Granata V, Grassi R, Fusco R, Palaia R, Delrio P, Carrafiello G, Azoulay D, Petrillo A, Curley SA. Radiofrequency Ablation and Microwave Ablation in Liver Tumors: An Update. Oncologist 2019;24:e990-e1005. [PMID: 31217342 DOI: 10.1634/theoncologist.2018-0337] [Cited by in Crossref: 75] [Cited by in F6Publishing: 63] [Article Influence: 25.0] [Reference Citation Analysis]
7 Wei N, Wu Z, Lu D, Xiao J, Zhou C, Chu S, Lv W. Expression of MMP-2 in residual VX2 liver tumor after transcatheter arterial embolization combined with portal venous embolization in an animal model. J Interv Med 2020;3:167-73. [PMID: 34805929 DOI: 10.1016/j.jimed.2020.08.006] [Reference Citation Analysis]
8 Ansari MY, Abdalla A, Ansari MY, Ansari MI, Malluhi B, Mohanty S, Mishra S, Singh SS, Abinahed J, Al-Ansari A, Balakrishnan S, Dakua SP. Practical utility of liver segmentation methods in clinical surgeries and interventions. BMC Med Imaging 2022;22:97. [PMID: 35610600 DOI: 10.1186/s12880-022-00825-2] [Reference Citation Analysis]
9 Swierz MJ, Storman D, Riemsma RP, Wolff R, Mitus JW, Pedziwiatr M, Kleijnen J, Bala MM. Percutaneous ethanol injection for liver metastases. Cochrane Database Syst Rev 2020;2:CD008717. [PMID: 32017845 DOI: 10.1002/14651858.CD008717.pub3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]